Design, Synthesis, Radiolabeling, and Biologic Evaluation of Three 18F-FDG-Radiolabeled Targeting Peptides for the Imaging of Apoptosis
- Sepideh Khoshbakht,
- Davood Beiki,
- Parham Geramifar,
- Farzad Kobarfard,
- Omid Sabzevari,
- Mohsen Amini,
- Noushin Bolourchian,
- Danial Shamshirian, and
- Soraya Shahhosseini
- Pages:271–279
- Published Online:4 March 2019
https://doi.org/10.1089/cbr.2018.2709
177Lu/153Sm-Ethylenediamine Tetramethylene Phosphonic Acid Cocktail: A Novel Palliative Treatment for Patients with Bone Metastases
- Mehrosadat Alavi,
- Farnaz Khajeh-Rahimi,
- Hassan Yousefnia,
- Mohammad Mohammadianpanah,
- Samaneh Zolghadri,
- Ali Bahrami-Samani, and
- Mohammad Ghannadi-Maragheh
- Pages:280–287
- Published Online:12 April 2019
https://doi.org/10.1089/cbr.2018.2683
89Zr-DFO-Cetuximab as a Molecular Imaging Agent to Identify Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma
- Raquel Benedetto,
- Adriana V.F. Massicano,
- Bryant K. Crenshaw,
- Renato Oliveira,
- Rui M. Reis,
- Elaine B. Araújo, and
- Suzanne E. Lapi
- Pages:288–296
- Published Online:13 March 2019
https://doi.org/10.1089/cbr.2018.2616
Antitumor Effects of Ruyiping on Cell Growth and Metastasis in Breast Cancer
- Pages:297–305
- Published Online:22 March 2019
https://doi.org/10.1089/cbr.2018.2703
Synthesis and Preliminary Biological Evaluation of 177Lu-Labeled Polyhydroxamic Acid Microparticles Toward Therapy of Hepatocellular Carcinoma
- Pages:306–315
- Published Online:11 June 2019
https://doi.org/10.1089/cbr.2018.2747
LncRNA KB-1471A8.2 Overexpression Suppresses Cell Proliferation and Migration and Antagonizes the Paclitaxel Resistance of Ovarian Cancer Cells
- Mi Zhang,
- Siyu Liu,
- Chenyang Fu,
- Xusu Wang,
- Min Zhang,
- Guangquan Liu,
- Chencheng Dai,
- Zhen Gong,
- Hanzi Xu,
- Ziyi Fu,
- Pengfei Xu,
- Juan Xu, and
- Xuemei Jia
- Pages:316–324
- Published Online:20 March 2019
https://doi.org/10.1089/cbr.2018.2698
Elevated Circulating CD4+CD25−Foxp3+ Regulatory T Cells in Patients with Nonsmall Cell Lung Cancer
- Pages:325–333
- Published Online:29 March 2019
https://doi.org/10.1089/cbr.2018.2672
miR-4429 Inhibits Tumor Progression and Epithelial-Mesenchymal Transition Via Targeting CDK6 in Clear Cell Renal Cell Carcinoma
- Hong Pan,
- Yejing Hong,
- Biying Yu,
- Li Li, and
- Xiaojian Zhang
- Pages:334–341
- Published Online:7 March 2019
https://doi.org/10.1089/cbr.2018.2697
89Zr-DFO-Cetuximab as a Molecular Imaging Agent to Identify Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma
Raquel Benedetto, Adriana V.F. Massicano, Bryant K. Crenshaw, Renato Oliveira, Rui M. Reis, Elaine B. Araújo, and Suzanne E. Lapi Read Now
Synthesis and Preliminary Biological Evaluation of 177Lu-Labeled Polyhydroxamic Acid Microparticles Toward Therapy of Hepatocellular Carcinoma
Usha Pandey, Suresh Subramanian, Samina Shaikh, Naresh Gamre, Sanjukta Kumar, and Ashutosh Dash Read Now
Design, Synthesis, Radiolabeling, and Biologic Evaluation of Three 18F-FDG-Radiolabeled Targeting Peptides for the Imaging of Apoptosis
Sepideh Khoshbakht, Davood Beiki, Parham Geramifar, Farzad Kobarfard, Omid Sabzevari, Mohsen Amini, Noushin Bolourchian, Danial Shamshirian, and Soraya Shahhosseini Read Now
177Lu/153Sm-Ethylenediamine Tetramethylene Phosphonic Acid Cocktail: A Novel Palliative Treatment for Patients with Bone Metastases
Mehrosadat Alavi, Farnaz Khajeh-Rahimi, Hassan Yousefnia, Mohammad Mohammadianpanah, Samaneh Zolghadri, Ali Bahrami-Samani, and Mohammad Ghannadi-Maragheh Read Now
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου